Literature DB >> 25950

Acid and neutral sphingomyelinases of rat brain. Activity in developing brain and regional distribution in adult brain.

M W Spence, J K Burgess.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 25950     DOI： 10.1111/j.1471-4159.1978.tb10804.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN： 0022-3042            Impact factor:   5.372


× No keyword cloud information.
  7 in total

1.  Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase.

Authors:  K Hofmann; S Tomiuk; G Wolff; W Stoffel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  Interindividual heterogeneity of molecular weight of human brain neutral sphingomyelinase determined by radiation inactivation method.

Authors:  T Levade; R Salvayre; M Potier; L Douste-Blazy
Journal:  Neurochem Res       Date:  1986-08       Impact factor: 3.996

3.  Neutral sphingomyelinase 2 (smpd3) in the control of postnatal growth and development.

Authors:  Wilhelm Stoffel; Britta Jenke; Barbara Blöck; Markus Zumbansen; Jürgen Koebke
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-11       Impact factor: 11.205

4.  Coenzyme Q-dependent functions of plasma membrane in the aging process.

Authors:  Plácido Navas; José Manuel Villalba; Giorgio Lenaz
Journal:  Age (Dordr)       Date:  2005-12-10

5.  Cambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective properties.

Authors:  Mariana Figuera-Losada; Marigo Stathis; Joelle M Dorskind; Ajit G Thomas; Veera Venkata Ratnam Bandaru; Seung-Wan Yoo; Nicholas J Westwood; Graeme W Rogers; Justin C McArthur; Norman J Haughey; Barbara S Slusher; Camilo Rojas
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

6.  SMPD3 deficiency perturbs neuronal proteostasis and causes progressive cognitive impairment.

Authors:  Wilhelm Stoffel; Britta Jenke; Inga Schmidt-Soltau; Erika Binczek; Susanne Brodesser; Ina Hammels
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

7.  Neutral sphingomyelinase mediates the co-morbidity trias of alcohol abuse, major depression and bone defects.

Authors:  Gunter Schumann; Johannes Kornhuber; Christian P Müller; Liubov S Kalinichenko; Christiane Mühle; Tianye Jia; Felix Anderheiden; Maria Datz; Anna-Lisa Eberle; Volker Eulenburg; Jonas Granzow; Martin Hofer; Julia Hohenschild; Sabine E Huber; Stefanie Kämpf; Georgios Kogias; Laura Lacatusu; Charlotte Lugmair; Stephen Mbu Taku; Doris Meixner; Nina Tesch; Marc Praetner; Cosima Rhein; Christina Sauer; Jessica Scholz; Franziska Ulrich; Florian Valenta; Esther Weigand; Markus Werner; Nicole Tay; Conor J Mc Veigh; Jana Haase; An-Li Wang; Laila Abdel-Hafiz; Joseph P Huston; Irena Smaga; Malgorzata Frankowska; Malgorzata Filip; Anbarasu Lourdusamy; Philipp Kirchner; Arif B Ekici; Lena M Marx; Neeraja Puliparambil Suresh; Renato Frischknecht; Anna Fejtova; Essa M Saied; Christoph Arenz; Aline Bozec; Isabel Wank; Silke Kreitz; Andreas Hess; Tobias Bäuerle; Maria Dolores Ledesma; Daniel N Mitroi; André M Miranda; Tiago G Oliveira; Erich Gulbins; Bernd Lenz
Journal:  Mol Psychiatry       Date:  2021-09-28       Impact factor: 15.992
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.